Archive for the ‘Q Fever’ Category

Q Fever (Chronic): Treatment

Monday, September 29th, 2008

Symptoms: Chronic Q fever usually occurs in patients with previous valvular heart disease, chronic renal insufficiency, or immunosuppression. Chronic Q fever generally implies endocarditis. Fever is generally low grade or absent. The disease should be suspected in all patients with culture-negative endocarditis.

Epidemiology: The primary sources of human infection are infected sheep, cattle, camel and goats. But cats, dogs, rabbits, and pigeons also can transmit C. burnetii to humans and cause Q fever. The wild reservoir includes ticks. In the infected animals C. burnetii localizes to the uterus and the mammary glands and is activated during pregnancy. C. burnetii is concentrated in the placenta and at the time of parturition (delivery), C. burnetii organisms are released into the air, and infection follows inhalation of aerosolized organisms by a susceptible host. So, C. burnetii can be a potential agent of bioterrorism.

Veterinarians, abattoir workers and other individuals who have contact with infected animals, mainly newborn animals or products of conception are at great risk of getting Q fever. C. burnetii is found in milk for weeks to months after parturition and ingestion of contaminated milk in some areas can be a major route of transmission to humans. But the vast majority of Q fever cases result from inhalation of contaminated aerosols.

Q fever can occur throughout the world except New Zealand and Antarctica.

Treatment: The treatment of chronic Q fever is very difficult and needs careful follow-up. Preferred regimen of treatment of chronic Q fever is doxycycline (100 mg twice a day) and hydroxychloroquine (200 mg thrice a day; plasma concentration maintained at 0.8–1.2 µg/ml) for 18 months. This is better than a regimen of doxycycline and ofloxacin. Q fever endocarditis requires determination of the minimal inhibitory concentration (MIC) of doxycycline for the patient’s isolate of C. burnetii and measurement of serum doxycycline levels. The doxycycline-hydroxychloroquine regimen is successful in patient with HIV infection and Q fever endocarditis. If doxycycline-hydroxychloroquine cannot be used, than at least two antibiotics active against C. burnetii like Rifampin (300 mg once daily) combined with doxycycline (100 mg twice daily) or ciprofloxacin (750 mg twice daily) should be used.

Treatment of C. burnetii infected aortic aneurysms is the same as that for Q fever endocarditis but surgical intervention is frequently required.

 

Q Fever (Acute): Treatment

Sunday, September 28th, 2008

The incubation period of Q fever is 3–30 days. The symptoms are nonspecific and mainly consist of fever, extreme fatigue, and severe headache. Chills, sweats, nausea, vomiting, and diarrhea may also occur. Cough is seen if patient develops Q fever pneumonia. Thrombocytopenia occurs in about 25% of patients, and reactive thrombocytosis with platelet counts sometimes exceeding 106/µL can develop during recovery.

Acute Q fever can complicate pregnancy and cause premature birth, abortion or neonatal death. Q fever in children is generally asymptomatic. Some cases of Q fever can lead to endocarditis (Q fever endocarditis).

Diagnosis: Diagnosis is by serology. Indirect immunofluorescence is sensitive and specific and is the method of choice for diagnosis. PCR (polymerase chain reaction) detects C. burnetii DNA in tissues.

Treatment of Q fever: Treatment of choice in acute Q fever is doxycycline 100 mgs twice a day for two weeks (14 days). Quinolones like ciprofloxacin, ofloxacin and gatifloxacin are also successful. Treatment of Q fever in pregnancy is with trimethoprim-sulfamethoxazole.

Prevention: A whole-cell vaccine (Q-Vax) is licensed in Australia and effectively prevents Q fever in abattoir (slaughterhouse) workers. Skin testing with intradermal diluted C. burnetii vaccine is done before administering vaccine. A history of possible Q fever is sought and vaccine is given only to patients with no history of Q fever and negative results in serologic and skin tests.

Good animal-husbandry practice is very important to prevent contamination of environment by C. burnetii. Only seronegative animals should be permitted in zoos.